Connecticut antibodies
Amid surge in COVID-19 patients, Yale New Haven Hospital forced to limit who gets potentially life-saving treatment
more at link
As more patients have developed COVID-19 symptoms over recent months, at least one Connecticut health provider has been forced to limit who receives potentially lifesaving treatment.
“Starting the week after Thanksgiving, the demand for the monoclonal [antibodies] started to far exceed our capacity to deliver it, so we needed to move to a more restrictive criteria,” said LeeAnn Miller, Yale New Haven’s chief pharmacy officer.
“If you are fully vaccinated, you’re not going to be prioritized as high as those who are not fully vaccinated.”